All at once, this concept commands attention, drives awareness, and demonstrates the benefit Gleolan provides. Oncology neurosurgeons can see the extent of tumor infiltration and delineate the margins between malignant and healthy tissue in real time during surgery to maximize the extent of their resection.
Winner of 2023 Pharma Choice Gold Award, Best Print Campaign
Invasive squamous cell carcinoma begins as actinic keratosis (AK). Most therapies for AK, and especially other photodynamic therapies, are indicated to treat only visible individual AK lesions. The concept informs HCPs that Ameluz empowers them to treat visible lesions and those that cause danger beneath the surface.
2022 Trailblazer Award, Best, Professional Website/Online Initiative
AUGTYRO is a next generation TKI-inhibitor that targets ROS1+ metastatic non-small cell lung cancer (mNSLC). Oncologists want to provide the most durable responses possible for their patients. The metal house represents the durable response HCPs can provide with AUGTRYO, to help patients experience higher-than-expected quality of life, for longer than they would with other TKI inhibitors.
Concept graced promotional materials in the campaign that won 2024 Pharma Choice Gold Award as the Best Professional Print Campaign. VNS Therapy is an implanted medical device proven to reduce seizures and death caused by drug-resistant epilepsy, and give patient back more time to live seizure-free.
Accrufer is an unusually effective oral iron supplement that delivers iron without causing the typical GI side effects associated with most oral iron supplements. The concept creatively reinforces the notion that Accrufer works hard to increase hemoglobin stores with lasting results.
Molybdenum cofactor deficiency (MoCD) is an ultra-rare, recessive, inborn error of metabolism characterized by sulfite intoxication. Doctors are unlikely to consider MoCD Type A until all the typical causes of neonatal seizures have been eliminated. For the child that is way too late. The concept was created to encourage awareness and testing that will ensure earlier diagnosis and treatment.